  Infection by many viruses begins with fusion of viral and cellular lipid
membranes, followed by entry of viral contents into the target cell and
ultimately, after many biochemical steps, integration of viral DNA into that of
the host cell. The early steps of membrane fusion and viral capsid entry are
mediated by adsorption to the cell surface, and receptor and coreceptor
binding. HIV-1 specifically targets CD4+ helper T-cells of the human immune
system and binds to the receptor CD4 and coreceptor CCR5 before fusion is
initiated. Previous experiments have been performed using a cell line
(293-Affinofile) in which the expression of CD4 and CCR5 concentration were
independently controlled. After exposure to HIV-1 of various strains, the
resulting infectivity was measured through the fraction of infected cells. To
design and evaluate the effectiveness of drug therapies that target the
inhibition of the entry processes, an accurate functional relationship between
the CD4/CCR5 concentrations and infectivity is desired in order to more
quantitatively analyze experimental data. We propose three kinetic models
describing the possible mechanistic processes involved in HIV entry and fit
their predictions to infectivity measurements, contrasting and comparing
different outcomes. Our approach allows interpretation of the clustering of
infectivity of different strains of HIV-1 in the space of mechanistic kinetic
parameters. Our model fitting also allows inference of nontrivial
stoichiometries of receptor and coreceptor binding and provides a framework
through which to quantitatively investigate the effectiveness of fusion
inhibitors and neutralizing antibodies.
